Position in RYTM
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$20,146,599
-$25,584,739 QoQ
Shares Held
231,650
-45.8% QoQ
Ownership
0.338%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.7273904597453.ToString("F0")%
Shared 0.ToString("F0")%
None 1.2726095402546944.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Mar 31, 2025CallValue
$429,057
CallShares
8,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. RYTM ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in RYTM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,146,599 | 231,650 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $45,731,338 | 427,236 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $42,449,731 | 420,336 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,960,655 | 252,582 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $429,057 | 8,100 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $14,413,559 | 272,108 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $14,233,698 | 254,264 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,014,853 | 76,634 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,707,578 | 65,942 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,433,911 | 171,565 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,951,350 | 85,955 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $610,973 | 26,651 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,448,630 | 87,849 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,499,933 | 84,077 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,569,636 | 191,265 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $309,557 | 12,635 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $31,153 | 7,507 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,760 | 500 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,033,728 | 103,580 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,057,468 | 80,970 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,568,729 | 80,119 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,698,099 | 126,850 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,007,218 | 101,151 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $915,709 | 42,257 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,485 | 246 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $88,655 | 5,825 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||